Affimed Logo
  • Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • Pipeline and Clinical Trials
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners and Collaborators
  • News and Events
  • Innately Affimed
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Corporate Governance Affimed
    • Annual General Meeting 2024
    • EGM 2024
    • Sustainability Affimed
    • Press Release Distribution
  • Careers
    • Culture
  • Contact
Menu

News and Events

See what’s new at Affimed

News

All categories
Earnings
Press Release
All years
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Affimed Announces Significant Investment by an Existing Shareholder

October 14, 2015

Affimed to Present Data on Potency of NK- and T-cell EGFRvIII TandAbs at SITC

October 6, 2015

Affimed to Present at the Leerink Partners Inaugural Immuno- Oncology Roundtable Conference

September 23, 2015

Affimed Reports Financial Results for Second Quarter 2015

August 4, 2015

Affimed Announces Second Quarter 2015 Financial Results and Corporate Update Conference Call

July 28, 2015

Affimed Added to Russell 2000® Index

June 30, 2015

Affimed Announces Opening of US Operations and Key US- based Hires

June 23, 2015

AbCheck and Pierre Fabre Pharmaceuticals Enter Into Strategic Research Partnership

June 17, 2015

Affimed ASCO Data Demonstrate Consistent Potency of NK- Cell-Engaging Combination Therapy with Checkpoint Modulators

May 29, 2015

Affimed ASCO Data for the CD33/CD3-TandAb Program Demonstrate that CD33 and CD3 binding affinities correlate with potent T-cell activation and cytotoxicity

May 29, 2015

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35

Events

All
Scientific
Investors

There are no events planned at the moment.

WebcastsMore events

Affimed GmbH
Gottlieb-Daimler Straße 2
68165 Mannheim
Germany

Phone: +49 (0)621-56003-0
Fax: +49 (0)621-56003-649
email hidden; JavaScript is required

  • Affimed Science and Technology
    • ICE® (innate cell engager) Molecules
    • ROCK® Platform
    • Publications and Posters
  • About Us
    • Management Board
    • Supervisory Board
    • Scientific Advisory Board
    • Partners and Collaborators
  • News and Events
  • Investors
    • Webcasts and Corporate Presentation
    • Analyst Coverage
    • Share Information
    • SEC and Financial Reports
    • Press Release Distribution
    • Corporate Governance
  • Careers
    • Culture

© 2025 Affimed GmbH

  • Data Protection
  • Imprint
  • Contact